SPOTLIGHT -
Leaders in cataract surgery agree that the field has benefited this yearby a number of important innovations-both by the manufacturers of equipmentand surgeons employing new techniques. Also, many promising new developmentsare on the horizon.
Aurion Biotech doses first Canadian patient in Phase 1/2 ABA-1, CLARA clinical trial of AURN001
EyePod: Modifier Gene Therapy: What is it?
Navigating ocular effects of cancer therapy: Insights from breast cancer and head-neck cancers
EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery
ABVC BioPharma reaches global licensing deal for ophthalmology pipeline
Plastic surgery: When specialties overlap